NL
NL · NL · NL-8e407313d11b
Tecentriq 840 mg concentraat voor oplossing voor infusie
ATC L01FF05
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerRoche Registration GmbH
CountryNL (NL)
ATC codeL01FF05
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/17/1220
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tecentriq-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Atezolizumab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123815",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"HISTIDINE, (L-)",
"POLYSORBAAT 20 (E 432)",
"SACCHAROSE",
"WATER VOOR INJECTIE"
],
"substances": [
"ATEZOLIZUMAB"
],
"leaflet_url": null,
"authorised_at": "2019/08/26",
"procedure_number": "EMEA/H/C/004143",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/17/1220",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L01FF05.
Access this data programmatically
Query Tecentriq 840 mg concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.